Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Lahm

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Validation of molecular and immunological factors with predictive importance in lung cancerJürgen R Fischer, Harald Lahm
International Journal of Cancer|September 30, 2004
Transcriptome analysis of a human colorectal cancer cell line shows molecular targets of insulin-like growth factor-binding protein-4 overexpressionDaniela Diehl, Harald Lahm, Eckhard Wolf, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 8, 2012
Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in ratsRalf Guenzinger, Harald Lahm, Michael Wottke, et al.
Cancer Research|March 5, 2004
Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanismsDaniela Diehl, Andreas Hoeflich, Eckhard Wolf, et al.
Journal of Receptor and Signal Transduction Research|December 31, 2002
Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrateBruno Schnyder, Harald Lahm, Martine Pittet, et al.
International Journal of Colorectal Disease|July 7, 2017
γ-Catenin acts as a tumor suppressor through context-dependent mechanisms in colorectal cancerJutta Maria Nagel, Harald Lahm, Andrea Ofner, et al.
Medicina (Kaunas, Lithuania)|August 3, 2005
[Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer]Marius Zemaitis, Raimundas Sakalauskas, Kestutis Malakauskas, et al.
Medicina (Kaunas, Lithuania)|March 11, 2005
[Aberrant promoter methylation of tumor suppressor genes in serum from lung cancer patients: frequency and correlation with clinicopathological characteristics]Marius Zemaitis, Norman Rieger, Jürgen Richard Fischer, et al.
Journal of Carcinogenesis|November 23, 2006
IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatmentDaniela Diehl, Doris Oesterle, Martin W Elmlinger, et al.
Veterinary Microbiology|August 16, 2011
A two year BTV-8 vaccination follow up: molecular diagnostics and assessment of humoral and cellular immune reactionsAlexandra Hund, Nicole Gollnick, Carola Sauter-Louis, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Validation of molecular and immunological factors with predictive importance in lung cancerJürgen R Fischer, Harald Lahm
International Journal of Cancer|September 30, 2004
Transcriptome analysis of a human colorectal cancer cell line shows molecular targets of insulin-like growth factor-binding protein-4 overexpressionDaniela Diehl, Harald Lahm, Eckhard Wolf, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 8, 2012
Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in ratsRalf Guenzinger, Harald Lahm, Michael Wottke, et al.
Cancer Research|March 5, 2004
Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanismsDaniela Diehl, Andreas Hoeflich, Eckhard Wolf, et al.
Journal of Receptor and Signal Transduction Research|December 31, 2002
Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrateBruno Schnyder, Harald Lahm, Martine Pittet, et al.
International Journal of Colorectal Disease|July 7, 2017
γ-Catenin acts as a tumor suppressor through context-dependent mechanisms in colorectal cancerJutta Maria Nagel, Harald Lahm, Andrea Ofner, et al.
Medicina (Kaunas, Lithuania)|August 3, 2005
[Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer]Marius Zemaitis, Raimundas Sakalauskas, Kestutis Malakauskas, et al.
Medicina (Kaunas, Lithuania)|March 11, 2005
[Aberrant promoter methylation of tumor suppressor genes in serum from lung cancer patients: frequency and correlation with clinicopathological characteristics]Marius Zemaitis, Norman Rieger, Jürgen Richard Fischer, et al.
Journal of Carcinogenesis|November 23, 2006
IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatmentDaniela Diehl, Doris Oesterle, Martin W Elmlinger, et al.
Veterinary Microbiology|August 16, 2011
A two year BTV-8 vaccination follow up: molecular diagnostics and assessment of humoral and cellular immune reactionsAlexandra Hund, Nicole Gollnick, Carola Sauter-Louis, et al.
Pageof 6